We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+19.36%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$74.6B
AUM Growth
+$11.6B
Cap. Flow
+$749M
Cap. Flow %
1%
Top 10 Hldgs %
23.84%
Holding
3,748
New
262
Increased
1,669
Reduced
1,459
Closed
235

Sector Composition

Rank Sector Weight
1 Technology 14.03%
2 Healthcare 8.95%
3 Financials 8.03%
4 Consumer Discretionary 6.23%
5 Industrials 5.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFTY icon
1551
CapForce IBD 50 ETF
FFTY
$80.5M
$2.61M ﹤0.01%
75,823
-13,607
-15% -$423K
E icon
1552
ENI
E
$79.1B
$2.59M ﹤0.01%
134,459
-12,406
-8% -$238K
MCY icon
1553
Mercury Insurance
MCY
$5.81B
$2.59M ﹤0.01%
63,513
+57,687
+990% +$2.32M
HYI
1554
Western Asset High Yield Opportunity Fund Inc
HYI
$135M
$2.58M ﹤0.01%
184,894
+31,746
+21% +$427K
SJNK icon
1555
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.81B
$2.56M ﹤0.01%
101,754
-8,401
-8% -$207K
EWT icon
1556
iShares MSCI Taiwan ETF
EWT
$11.6B
$2.56M ﹤0.01%
63,665
-1,227
-2% -$45.6K
DCOM icon
1557
Dime Commercial Bancshares
DCOM
$1.82B
$2.56M ﹤0.01%
112,051
-22
-0% -$452
TPR icon
1558
Tapestry
TPR
$25.9B
$2.56M ﹤0.01%
192,722
+48,950
+34% +$695K
GMAB icon
1559
Genmab
GMAB
$19.3B
$2.56M ﹤0.01%
75,450
-48,064
-39% -$1.31M
GLMD icon
1560
Galmed Pharmaceuticals
GLMD
$4.39M
$2.56M ﹤0.01%
2,970
+1,058
+55% +$892K
RDFN
1561
DELISTED
Redfin
RDFN
$2.55M ﹤0.01%
60,939
-8,344
-12% -$220K
VIVO
1562
DELISTED
Meridian Bioscience Inc
VIVO
$2.55M ﹤0.01%
109,592
+12,736
+13% +$185K
CADE
1563
DELISTED
Cadence Bancorporation
CADE
$2.55M ﹤0.01%
288,093
+111,467
+63% +$796K
G icon
1564
Genpact
G
$5.78B
$2.55M ﹤0.01%
69,831
+36,764
+111% +$1.24M
ICF icon
1565
iShares Select U.S. REIT ETF
ICF
$2.11B
$2.55M ﹤0.01%
50,534
-56,040
-53% -$2.76M
LVHD icon
1566
Franklin US Low Volatility High Dividend Index ETF
LVHD
$630M
$2.55M ﹤0.01%
88,475
-14,201
-14% -$397K
ACM icon
1567
Aecom
ACM
$8.19B
$2.53M ﹤0.01%
67,339
-3,491
-5% -$125K
HTGC icon
1568
Hercules Capital
HTGC
$3.17B
$2.53M ﹤0.01%
241,765
+1,329
+0.6% +$13.5K
SLAB icon
1569
Silicon Laboratories
SLAB
$7.28B
$2.53M ﹤0.01%
25,217
+3,823
+18% +$357K
IQI icon
1570
Invesco Quality Municipal Securities
IQI
$541M
$2.53M ﹤0.01%
212,104
-31,538
-13% -$369K
CCJ icon
1571
Cameco
CCJ
$42.6B
$2.53M ﹤0.01%
246,470
+52,133
+27% +$521K
PBF icon
1572
PBF Energy
PBF
$8.81B
$2.53M ﹤0.01%
246,781
+95,201
+63% +$952K
WAFD icon
1573
WaFd
WAFD
$2.81B
$2.52M ﹤0.01%
93,906
+2,386
+3% +$61.5K
FMS icon
1574
Fresenius Medical Care
FMS
$12.6B
$2.5M ﹤0.01%
57,879
-5,706
-9% -$225K
BHC icon
1575
Bausch Health
BHC
$2.37B
$2.5M ﹤0.01%
136,721
+90,626
+197% +$1.6M

Similar funds

Raymond James & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Raymond James & Associates held 3,748 positions worth $74.6B, up 18% from $63B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2020 filing shows 262 new, 1,669 increased, 1,459 reduced and 235 closed positions. Its largest new stake was Carrier Global: 1,148,017 shares worth $25.5M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $487M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2020 buy was Carrier Global: 1,148,017 shares worth $25.5M.
  • Raymond James & Associates added most to iShares Broad USD High Yield Corporate Bond ETF in Q2 2020, an estimated $312M increase.
  • Raymond James & Associates's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $487M.
  • Raymond James & Associates fully exited Raytheon Company in Q2 2020, selling an estimated $73.9M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $74.6B portfolio in Q2 2020.
  • Raymond James & Associates opened 262 new positions and closed 235 in Q2 2020.
  • Raymond James & Associates's portfolio value rose 18% quarter-over-quarter to $74.6B.

Based on Raymond James & Associates's 13F filing for Q2 2020, filed 28 Jul 2020.